|
⚲
|
| Keyboard |
| Lintal Ellen M
✚
|
|
|---|---|
| CIK # | 0001788908 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001788908] | |
| 4 | [0001788908] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hemispherx Biopharma Inc | |
| Lintal Ellen M |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Hemispherx Biopharma Inc AIM
Options · derivative
|
2022-03-03 | Grant | 50,000 | $0.00 | |
|
Hemispherx Biopharma Inc AIM
Options · derivative
|
2021-11-30 | Grant | 100,000 | $0.00 | |
|
Hemispherx Biopharma Inc AIM
Options · derivative
|
2020-12-09 | Grant | 75,000 | $0.00 | |
|
Hemispherx Biopharma Inc AIM
Common Stock
|
2019-12-31 | Grant | 3,931 | $0.53 | 2,083 |
|
Hemispherx Biopharma Inc AIM
Common Stock
|
2019-12-13 | Grant | 4,789 | $0.44 | 2,107 |
|
Hemispherx Biopharma Inc AIM
Common Stock
|
2019-11-29 | Grant | 5,208 | $0.40 | 2,083 |
|
Hemispherx Biopharma Inc AIM
Common Stock
|
2019-11-15 | Grant | 4,433 | $0.47 | 2,084 |
|
Hemispherx Biopharma Inc AIM
Common Stock
|
2019-10-31 | Grant | 4,167 | $0.50 | 2,084 |